Cargando…
Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria
X-linked glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzymopathy. The severe Mediterranean variant (G6PD Med) found across Europe and Asia is thought to confer protection against malaria, but its effect is unclear. We fitted a Bayesian statistical model to observed G...
Autores principales: | Awab, Ghulam R, Aaram, Fahima, Jamornthanyawat, Natsuda, Suwannasin, Kanokon, Pagornrat, Watcharee, Watson, James A, Woodrow, Charles J, Dondorp, Arjen M, Day, Nicholas PJ, Imwong, Mallika, White, Nicholas J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884069/ https://www.ncbi.nlm.nih.gov/pubmed/33543710 http://dx.doi.org/10.7554/eLife.62448 |
Ejemplares similares
-
A Population Survey of the Glucose-6-Phosphate Dehydrogenase (G6PD) 563C>T (Mediterranean) Mutation in Afghanistan
por: Jamornthanyawat, Natsuda, et al.
Publicado: (2014) -
Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan
por: Awab, Ghulam R, et al.
Publicado: (2013) -
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
por: Awab, Ghulam Rahim, et al.
Publicado: (2010) -
Measurement of gene amplifications related to drug resistance in Plasmodium falciparum using droplet digital PCR
por: Srisutham, Suttipat, et al.
Publicado: (2021) -
Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017
por: Rakmark, Kasama, et al.
Publicado: (2020)